Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group.
P
P
Fenaux
E
E
Wattel
E
E
Archimbaud
M
M
Sanz
B
B
Hecquet
N
N
Fegueux
A
A
Guerci
H
H
Link
M
M
Fey
S
S
Castaigne
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D010865:Pilot Projects; D012008:Recurrence; D014212:Tretinoin / Q000627:therapeutic use*
D014212:Tretinoin